HR 5377
117th Congress
House
Health
Cancer
Health care costs and insurance
Health care coverage and access
Health promotion and preventive care
Medicaid
Medical tests and diagnostic methods
Medicare
Poverty and welfare assistance
State and local government operations
Cancer Patient Equity Act of 2021
Introduced: September 27, 2021
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 28, 2021
Referred to the Subcommittee on Health.
Sep 27, 2021
Referred to the Subcommittee on Health.
Sep 27, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 27, 2021
Introduced in House
Plain-English summary
Cancer Patient Equity Act of 2021
This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.
Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
4